logo-loader

EXMceuticals now '100% focused on being a refining bioscience business in Portugal'

Published: 11:11 14 Sep 2020 EDT

EXMceuticals Inc's (CSE:EXM) Jonathan Summers speaks to Proactive London's Katie Pilbeam about their cannabis research and development.

Summers explains that the company has recently transitioned from being active in Africa to focusing their attentions solely onto Portugal.

The company recently announced securing a COVID-19 R&D-focused grant from the European Union and the Portuguese Government to accelerate their operations on creating a disposable filter for a mask.

EXMceuticals announced LOI with Plena Global to provide THC Distillate in...

EXMceuticals Inc (CSE: EXM) CEO Jonathan Summers joined Steve Darling from Proactive Vancouver to discuss the company signing a Letter of Intent to purchase up to 200 kg of GMP compliment THC Distillate from Plena Global for use in their Portugal facility. Summers telling Proactive about this...

on 06/12/2020